Live Breaking News & Updates on Debjit Chattopadhyay

Stay updated with breaking news from Debjit chattopadhyay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United-states , Yanan-zhu , Debjit-chattopadhyay , Kostas-biliouris , Laura-sepp-lorenzino , Ian-karp , Glenn-goddard , John-leonard , David-lebwohl , Brian-cheng , Troy-langford , Maury-raycroft

Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript

VRTX earnings call for the period ending March 31, 2024. ....

France , Brazil , Bahrain , Australia , New-zealand , Canada , Switzerland , United-states , American , Americans , Salveen-richter , Colin-bristow

Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2023 Earnings Call Transcript

Operator: Thank you for standing by and welcome to the Krystal Biotech Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a lesson-only mode. ....

Japan , France , Italy , Germany , United-states , Spain , America , Japanese , Tim-lugo , Gavin-clark-gartner , Christine-wilson , Alec-stranahan

Krystal Biotech Analysts Increase Their Forecasts Following Q4 Results - Krystal Biotech (NASDAQ:KRYS)

Krystal Biotech, Inc. (NASDAQ: KRYS) reported better-than-expected financial results for its fourth quarter on Monday. ....

Debjit-chattopadhyay , Yigal-nochomovitz , Krishs-krishnan , Krystal-biotech-inc , Citigroup , Krystal-biotech ,

Why Soleno Therapeutics Stock Ticked Higher on Thursday

The latest pundit take on the stock provided a good reason for bulls to snap it up. ....

Debjit-chattopadhyay , Drug-administration , Soleno-therapeutics , Diazoxide-choline , Prader-willi-syndrome , New-drug-application , Motley-fool-stock-advisor , Stock-advisor ,